【財華社訊】港交所權益資料顯示,昭衍新藥(06127.HK)獲Aggregate of abrdn plc affiliated investment management entities於1月7日在場內以每股平均價54.0177港元增持24.68萬股,涉資約1333.16萬港元。增持後,Aggregate of abrdn plc affiliated investment management entities的最新持股數目為364.70萬股,持股比例由5.60%增持至6.01%。(出處:FinetAI)
港交所原文